scispace - formally typeset
Journal ArticleDOI

A Review on Pharmacological, Anti-oxidant Activities and Phytochemical Constituents of a Novel Lichen Parmotrema Species

Reads0
Chats0
TLDR
In this article, a review dealt with the in-depth potentiality of this novel lichen Parmotrema species and its role in pharmacology and concluded that the free radical scavenging activity and cytotoxicity specifically towards cancer cells infer that this lichen genus can have potential anti-cancer properties and should be extensively investigated for pharmaceutical purposes.
Abstract
Increased resistance and side effects of synthetic pharmaceutical drugs have led to the exploration of bioactive compounds from alternative sources. Therefore, research on drug development from members of natural sources has gained much importance. Lichens are a unique association of fungi and algae, producing a wide array of secondary metabolites which has immense pharmacological activities. Lichen extracts have been used in traditional systems of medicines and are known to cure several diseases. Parmotrema is a large genus of foliose lichen belonging to the family Parmeliaceae. Parmeloid lichens are a diverse and ubiquitous group of lichens. Members of the Parmeliaceae family have been used in several traditional systems of medicines. One hundred and nine articles have been reported till date regarding pharmacological activities of Parmotrema species. Studies reveal that Parmotrema exhibits numerous biological activities ranging from anti-microbial, anti-fungal, anti-oxidative, and anti-proliferative properties. These properties can be attributed to the presence of pharmacologically active compounds like depsides, depsidones, phenolics, polysaccharides, lipids, diphenyl ethers, and dibenzofurans. The free radical scavenging activity and cytotoxicity specifically towards cancer cells infer that this lichen genus can have potential anti-cancer properties and should be extensively investigated for pharmaceutical purposes. This review dealt with the in-depth potentiality of this novel lichen Parmotrema species and its role in pharmacology.

read more

Citations
More filters
Journal ArticleDOI

Recent literature on lichens—267

James C. Lendemer
- 27 Dec 2022 - 
TL;DR: In this paper , the authors present a taxonomic survey of lichen-derived products and their applications in the field of bioengineering, including the use of lichens as a sustainable source of natural dyes.
References
More filters
Journal ArticleDOI

Metabolomic Analysis of Two Parmotrema Lichens: P. robustum (Degel.) Hale and P. andinum (Mull. Arg.) Hale Using UHPLC-ESI-OT-MS-MS.

TL;DR: This report shows that this technique is effective and accurate for rapid chemical identification of lichen substances and the compounds identified could serve as chemotaxonomic markers to differentiate these ruffle lichens.
Journal ArticleDOI

Tsavoenones A-C: unprecedented polyketides with a 1,7-dioxadispiro[4.0.4.4]tetradecane core from the lichen Parmotrema tsavoense.

TL;DR: New racemic dispiranic polyketides, tsavoenones A (1), B (2) and C (3), having a novel 1,7-dioxadispiro[4.0.4.4]tetradecane scaffold were isolated from the foliose lichen Parmotrema tsavoense and displayed a moderate activity against human myelogenous leukemia K562 cell line.
Journal ArticleDOI

Biological activities of four Parmotrema species of Malaysian origin and their chemical constituents

TL;DR: The present study is the first evaluation of antibacterial activity on lichens of Malaysian origin and to the authors' knowledge; the first reported study on the biological activity of praesorediosic acid and Parmotrema rampoddense.
Journal ArticleDOI

Phylogenetic Analysis of Parmotrema (Parmeliaceae: Lichenized Ascomycotina)

TL;DR: The parsimony analysis indicates that Rimelia and Canomaculina may be better treated as subgenera of Parmotrema and that these traditionally used characters are not helpful discriminators at this level.
Related Papers (5)